Difference in vasoconstrictors: oxymetazoline vs. brimonidine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Difference in vasoconstrictors: oxymetazoline vs. brimonidine

Published:2019-08-12 Issue:2 Volume:32 Page:137-143
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Okwundu Nwanneka¹,Cline Abigail¹,Feldman Steven R.¹²³^ORCID

Affiliation:

1. Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA

2. Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA

3. Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2019.1639606

Reference29 articles.

1. Reduction in ultraviolet B light-induced erythema by oxymetazoline and brimonidine is mediated by different α-adrenoceptors

2. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea

3. Oxymetazoline hydrochloride cream for facial erythema associated with rosacea

4. Management of facial erythema of rosacea: What is the role of topical α-adrenergic receptor agonist therapy?

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Common Dermatologic Conditions;Medical Clinics of North America;2024-09

2. Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial;Journal of the American Academy of Dermatology;2023-06

3. Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta‐analysis;Journal of Cosmetic Dermatology;2023-05-02

4. The role of the topical nasal decongestant oxymetazoline as a novel therapeutic option for post‐acne erythema: A split‐face, double‐blind, randomized, placebo‐controlled trial;The Journal of Dermatology;2023-02-20

5. Progression of Local Treatment of Post-Acne Erythema;Advances in Clinical Medicine;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3